Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 16, 2025 09:00 ET | Source: Optec International, Inc.

New Optec CEO Updates Shareholders

New Optec CEO Updates Shareholders
March 08, 2022 13:49 ET | Source: Optimi Health Corp.

Optimi Health Announces Investor Relations Agreement

VANCOUVER, British Columbia, March 08, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom...
February 16, 2022 09:00 ET | Source: Optimi Health Corp.

Optimi Health Approved to Supply Psilocybin Under Health Canada’s Special Access Program

VANCOUVER, British Columbia, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom...
October 19, 2021 09:00 ET | Source: Optimi Health Corp.

Optimi Health Appoints Principal Investigator for Clinical Dosing Study

VANCOUVER, British Columbia, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom...
July 13, 2021 09:00 ET | Source: Optimi Health Corp.

Optimi Health Joins First Psychedelic Exchange Traded Fund

VANCOUVER, British Columbia, July 13, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a vertically integrated developer of mushroom...
June 23, 2021 09:00 ET | Source: Optimi Health Corp.

Optimi Health Engages U.S. Based Law Firm for Patent Support

VANCOUVER, British Columbia, June 23, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a vertically integrated developer of mushroom...
March 02, 2021 09:00 ET | Source: Optimi Health Corp.

OPTIMI HEALTH and NUMINUS WELLNESS to Conduct Psychedelic Lab Research and Development

Agreement propels development of safe and effective proprietary products and formulations for the emerging psychedelic industry VANCOUVER, British Columbia, March 02, 2021 (GLOBE NEWSWIRE) --...
February 25, 2021 09:00 ET | Source: Optimi Health Corp.

Optimi Health Corp. Completes Oversubscribed $20.7 Million Initial Public Offering, and Announces Listing on the CSE

NOT FOR DISTRIBUTION IN THE UNITED STATES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (“Optimi” or the...
February 18, 2021 15:18 ET | Source: Optimi Health Corp.

Optimi Health Corp. Receives Receipt For Final Prospectus and Conditional Approval to List on the CSE

NOT FOR DISTRIBUTION IN THE UNITED STATES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (“Optimi” or the “Company”),...